Marking its 7th year, the "2012-2013 Consumer Electronics Top 10 Brands from China" competition ("The Competition") started recently. This event, held in the context of 3C convergence and penetration, actively focuses on the intelligent innovation of Chinese consumer electronic brands to help them capture future opportunities more precisely and forcefully in the international arena. So far, there are 20 candidate brands from China and abroad, including Haier, Hisense, TCL, Changhong, Skyworth, Great Wall, Konka, Tongfang, Huawei, Acer, BOE, Midea, Founder, ... read more
ViroPharma Incorporated (NASDAQ: VPHM) today announced that Health Canada has granted a Notice of Compliance (NOC) and approved a New Drug Submission (NDS) for Cinryze(TM) (C1 inhibitor [human]). Approval of Cinryze was granted for routine prevention of angioedema attacks in adult and adolescents with hereditary angioedema (HAE). Until now, there have been no approved plasma derived C1 inhibitor therapies for routine prevention of HAE attacks in Canada. ViroPharma's Canadian headquarters are located in Oakville, Ontario. We anticipate ... read more
PTC Therapeutics, Inc. (PTC) today announced the receipt of a $1 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to discover antiviral agents for the treatment of dengue fever, a mosquito-borne disease that is a leading cause of illness and death in tropical and subtropical regions around the world. The one-year grant will support research into promising compounds identified by PTC's proprietary GEMS(TM) (Gene Expression Modulation by ... read more
AMRI (NASDAQ: AMRI) announced today that Steven R. Hagen, Ph.D., has been promoted to senior vice president of pharmaceutical development and manufacturing. He will continue to report to AMRI Chairman, President and CEO Thomas E. D'Ambra, Ph.D. Dr. Hagen is responsible for approximately two-thirds of AMRI's contract operations, including Chemical Development, Analytical and Pharmaceutical Quality Services, Small Scale cGMP Manufacturing of active ingredients and dosage forms, and Large Scale Commercial Manufacturing. These operations encompass facilities located in Albany, Rensselaer and ... read more
During a recent test at Fort Benning, Ga., Raytheon Company's (NYSE: RTN) BattleGuard modular weapon station struck targets with every burst of ammunition fired, proving its precision engagement capability under both stationary and moving engagement scenarios.
(Photo: http://photos.prnewswire.com/prnh/20121022/NE95914 )
The maturity of the BattleGuard system was demonstrated at a live-fire exercise on an A3 Bradley Fighting Vehicle by engaging troop and vehicle targets at ranges that approach the maximum effective ranges of the weapon systems. That allows U.S. Army soldiers and ... read more
ProTek Devices(TM) today announced a new business line currently targeted at LED lighting manufacturers. The product line consists of individual unpackaged die available in wafer form. The die in wafer form are available as unidirectional and bidirectional electrostatic discharge (ESD) protection diodes. ProTek Devices' new LED die solutions meet various LED lamp manufacturing needs. In addition to LED lighting manufacturers, other applications include digital display boards; automotive LEDs; backlight LEDs and solid-state lighting.
The new LED die is provided with a ... read more
Cardiocom, the Experts in Telehealth, introduces four new communication solutions: LinkView(TM), Attentiv(TM), NetResponse(TM) and TeleResponse(TM) to its proven telehealth platform.
LinkView((TM)) is a sophisticated home telehealth solution that offers interactive video communication, color touch screen and vital sign measurement for patients in a single integrated package.
Attentiv((TM) )is an advanced health monitoring and personal emergency response system that provides patients with around-the-clock monitoring for safer and more independent lives.
NetResponse((TM)) is an interactive web based telehealth solution that offers daily ... read more
Digital Assent, a fast-growing healthcare media and marketing company headquartered in Atlanta, today announced that the Technology Association of Georgia (TAG), the state's leading association dedicated to the promotion and economic advancement of Georgia's technology industry, has named company founder and CEO Andrew Ibbotson a finalist for its third annual Mobile Marketer of the Year Award.
One of nine award categories with over 60 nominees in the running, the Mobile Marketer of the Year represents an individual who is on ... read more
Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and the enforcement of federal antitrust laws, is investigating potential wrongdoing at Vascular Solutions Inc. ("Vascular" or the "Company") (Nasdaq: VASC). The investigation focuses on whether certain executive officers and directors of Vascular breached their fiduciary duties by causing the Company to illegally market its Vari-Lase medical device for unapproved uses. The Vari-Lase device is an endovenous laser system that is used to treat varicose ... read more
A recent high-profile incident involving drug contamination and patient deaths associated with a compounding pharmacy underscores the safety challenges associated with current drug compounding processes throughout the country. Fortunately, there is a system available today that may help ensure the sterility of drugs during the drug compounding process. The Diana(TM) Hazardous Drug Compounding System, manufactured by ICU Medical, Inc. (NASDAQ: ICUI), is the world's only needlefree user-controlled automated compounding system for the safe reconstitution and preparation of hazardous drugs.
Originally ... read more
New Phase 3 study findings showed significantly more patients with moderately to severely active ulcerative colitis (UC) who responded to induction therapy with subcutaneously administered SIMPONI(®) (golimumab) maintained clinical response through week 54, the primary endpoint of the study, compared with patients receiving placebo. Investigators will report clinical response, clinical remission and mucosal healing results through one year from the Janssen Research & Development, LLC (Janssen)-sponsored Program of Ulcerative Colitis Research Studies Utilizing an Investigational Treatment (PURSUIT)-Maintenance investigational study ... read more
CQ Roll Call, an Economist Group business, announced today the launch of CQRC Engage, its revolutionary new advocacy platform. Recognizing the evolving advocacy landscape and the need to reach audiences with greater efficiencies, CQRC Engage will provide groundbreaking digital tools that help organizations affect change and move advocacy forward.
"CQRC Engage is a game-changer because it addresses a market shift where there is a change in behavior towards engagement and thought leadership," says Peter Anthony, Senior Vice President and ... read more
Equifax announced today at the 2012 Mortgage Bankers Association Annual Convention & Expo the availability of its Spectrum(TM) Verification Services Platform, which strengthens lender confidence by streamlining the verification processes through underwriting, QA and closing.
(Logo: http://photos.prnewswire.com/prnh/20060224/CLF037LOGO )
Equifax developed Spectrum to help lenders gain efficiencies and improve overall loan quality production, which helps mitigate loan repurchase risk. Fully automated, Spectrum rapidly delivers loan-level verifications by combining unique data assets with integrated workflow processes to reduce fraud, improve overall loan quality ... read more
ClearOne (NASDAQ: CLRO), a global provider of audio visual communication solutions, today announced a distribution agreement with Ingram Micro Inc., (NYSE: IM). Under the terms of the agreement, Ingram Micro will distribute ClearOne's new line of software-based video conferencing solutions and its USB, analog and VoIP conference phones to authorized technology resellers in the U.S.
"As the IT / AV industries continue to converge, Ingram Micro is well positioned to help us identify new business opportunities and drive greater growth within ... read more
PersonalLoansForBadCredit.net, leading online personal loans comparison site, announces some key refreshes to its online location. The platform has optimized its layout, added new content and repowered its lender database to ensure the most robust search experience for individuals searching for lenders.
In the coming weeks, the site will be continuing its content drive and will focus on publishing helpful articles on a range of bad credit and personal finance topics. In addition to being an online aggregator for a personal loan ... read more
TelcoTV, the largest conference and expo focused on video broadband network service providers in the U.S., is preparing for its best-ever event from October 24 to 26, 2012 at the Las Vegas Hotel, Nevada. Operators large and small - as well as the equipment, services and content vendors that serve them - will come together to discuss and learn about the latest technologies, trends and regulatory insights in the business. For more information or to register to attend, visit www.telcotvonline.com.
(Logo: ... read more
Marvell (Nasdaq: MRVL) today announced a collaboration with Lenovo (HKSE: 0992) (ADR: LNVGY) in which Marvell's award-winning and best-in-class ARMADA® 1500 Series DTV SoC platform (88DE3100) will power Lenovo's new groundbreaking S-Series of Android Smart TVs. Lenovo's latest series of advanced and cost effective Smart TVs are geared specifically for the mass market representing Marvell's continued leadership and dedication in helping to drive the global adoption of Smart TVs.
"I'm very proud that Marvell's world-class advanced and innovative technologies ... read more
VentiRx Pharmaceuticals, Inc. announced today the initiation of a randomized, placebo-controlled, Phase 2 trial evaluating VTX-2337 in combination with Doxil(®) (pegylated liposomal doxorubicin) in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer who have failed prior platinum-based chemotherapy. The trial will investigate whether combining VTX-2337 with Doxil(®), a standard second-line chemotherapy for ovarian cancer patients, has the potential to improve survival outcomes compared to Doxil(®) alone in this patient population.
The randomized, double-blind, placebo-controlled Phase ... read more
Receptos, Inc., announced today that its selective sphingosine?1? phosphate receptor 1 (S1P1) modulator, RPC1063, has been administered to the first patient in a Phase 2/3 study. RPC01-201, a Phase 2/3 placebo-controlled (Phase 2) and active comparator-controlled (Phase 3) trial, is the first of two planned pivotal studies for RPC1063 in the indication of relapsing multiple sclerosis (RMS).
The Phase 2 portion of RPC01-201 is a randomized, double-blind comparison of two doses of RPC1063 to a placebo control in patients with RMS. ... read more
ASTRO Booth #5019 -- Varian Medical Systems (NYSE: VAR) will showcase new technologies that highlight its expanding leadership position in the radiation oncology market at the 54(th) annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston starting on Sunday. The company will exhibit a portfolio of comprehensive oncology IT solutions, a real-time planning tool for ultrasound-guided high-dose-rate brachytherapy treatment planning*, and new capabilities* of the Calypso® system for real-time tumor tracking and motion management that will ... read more